CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function

Bone Marrow Transplantation
D JingM Bornhäuser

Abstract

Therapeutic application of natalizumab, an anti-CD49d Ab, in patients with multiple sclerosis (MS) has been associated with increased levels of circulating CD34+ progenitors. We analyzed the frequency, phenotype and functional activity of CD34+ HSC in blood and BM of patients with MS who were treated with natalizumab. Compared with healthy controls and untreated MS patients, natalizumab treatment increased CD34+ cells in the peripheral blood 7-fold and in BM 10-fold. CD34+ cells derived from blood and marrow of natalizumab-treated patients expressed less of the stem cell marker CD133, were enriched for erythroid progenitors (CFU-E) and expressed lower levels of adhesion molecules than G-CSF-mobilized CD34+ cells. The level of surface CXCR-4 expression on CD34+ cells from patients treated with natalizumab was higher compared with that of CD34+ cells mobilized by G-CSF (median 43.9 vs 15.1%). This was associated with a more than doubled migration capacity toward a chemokine stimulus. Furthermore, CD34+ cells mobilized by natalizumab contained more mRNA for p21 and less for matrix metallopeptidase 9 compared with G-CSF-mobilized hematopoietic stem cell (HSC). Our data indicate that G-CSF and CD49d blockade mobilize different HSC s...Continue Reading

References

Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T Papayannopoulou, B Nakamoto
Feb 24, 2006·Nature Reviews. Immunology·Anne Wilson, Andreas Trumpp
Apr 28, 2006·The New England Journal of Medicine·Edward A Copelan
Apr 2, 2008·The Journal of Experimental Medicine·Yuchun NieYong-Rui Zou
Sep 11, 2009·The New England Journal of Medicine·Werner WenningRalf Gold
Sep 11, 2009·The New England Journal of Medicine·Hans LindåClaes Martin

❮ Previous
Next ❯

Citations

Nov 30, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Harold L Atkins, Mark S Freedman
Mar 7, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Clemens WarnkeAnna Fogdell-Hahn
Jan 31, 2014·Blood Reviews·Rusudan K Hopman, John F DiPersio
Dec 30, 2015·Annals of the New York Academy of Sciences·Melissa van PelKoen Schepers
Mar 16, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·R Y Loyaga-RendonC E Koval
Jan 7, 2014·Clinical and Experimental Immunology·T KoudriavtsevaP Cordiali-Fei
Jun 6, 2013·Clinical & Developmental Immunology·Cillian F De Gascun, Michael J Carr
Jul 15, 2015·Bioinorganic Chemistry and Applications·Yuanyuan ZhangFan Jiang
Sep 10, 2014·BioMed Research International·Maria K AngelopoulouPanayiotis Tsirigotis
Oct 25, 2013·Cell Adhesion & Migration·Sofieke E KlamerCarlijn Voermans
Feb 5, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Christoph RobierStefan Quasthoff
Nov 14, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Clemens WarnkeBernd C Kieseier
Nov 17, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Clemens WarnkeBernd C Kieseier
Apr 23, 2019·Annals of the New York Academy of Sciences·Evert-Jan F M de KruijfMelissa van Pel
Oct 16, 2014·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Neha Bakshi, Kalyani Singh
Aug 28, 2019·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Amir KhaliliIlker Kudret Sariyer
Jun 9, 2020·Clinical and Translational Medicine·Kira GroenJeannette Lechner-Scott
Dec 24, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Arielle Glatman ZaretskyChristopher A Hunter
May 12, 2017·Biological Chemistry·Benedetta Assetta, Walter J Atwood
Dec 3, 2016·International Journal of Hematology·Mélanie J DominguesBenjamin Cao
Jun 14, 2017·Multiple Sclerosis Journal - Experimental, Translational and Clinical·Kira GroenJeannette Lechner-Scott
Oct 20, 2020·Frontiers in Immunology·Kathy KhoyBrigitte Le Mauff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.